Suggestions
Tom Fleming
CEO & Co-Founder @ Arctoris | Expertise in Drug Discovery
Tom Fleming is the Chief Executive Officer (CEO) and Co-Founder of Arctoris, a company based in Oxford, United Kingdom.1 He holds several prestigious titles, including MChem (Master of Chemistry), FRSA (Fellow of the Royal Society of Arts), FRSB (Fellow of the Royal Society of Biology), and FRSC (Fellow of the Royal Society of Chemistry).1
Professional Background
Fleming's career at Arctoris began in January 2018 when he co-founded the company.1 His background is rooted in chemistry and biology, as evidenced by his educational qualifications and professional affiliations.
Education and Research
Tom Fleming completed his DPhil (Doctor of Philosophy) at Keble College, Oxford, from 2014 to 2018.1 During his academic career, he also gained valuable industry experience through various research positions:
- Visiting Research Scientist at GSK in Stevenage, UK (July 2017 - December 2018)
- Visiting Research Scientist at Evotec in Toulouse, France (July 2016 - December 2016)
Additional Roles and Achievements
Fleming has held several other notable positions that have contributed to his expertise in the fields of artificial intelligence, technology, and entrepreneurship:
- Member of the UK Young Academy (January 2023 - Present)
- Participant in Tech Nation's Upscale 8.0 and Applied AI programs
- SME Leader at the Royal Academy of Engineering (July 2019 - October 2020)
- Industrial Fellow at the Royal Commission for the Exhibition of 1851 (October 2016 - September 2020)
Professional Recognitions
Tom Fleming's expertise and contributions to his field have been recognized through several prestigious fellowships:
- Fellow of the Royal Society of Arts (RSA)
- Fellow of the Royal Society of Biology (awarded April 2022)
- Fellow of the Royal Society of Chemistry (awarded May 2022)
These accomplishments highlight Tom Fleming's significant contributions to the fields of chemistry, biology, and technology, as well as his leadership role in the innovative company Arctoris.